Pharmacokinetics of Alglucosidase Alfa in Patients Aged 8 Years of Age and Older

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-022231-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to characterize the pharmacokinetics of alglucosidase alfa manufactured at the 4000 L scale in patients 8 years of age and older who have a confirmed diagnosis of Pompe disease.


Critère d'inclusion

  • Pompe disease (acid alpha-glucosidase deficiency)

Liens